Nippon India Pharma Fund(G)-Direct Plan
View the regular plan of this scheme
Rs 470.5524 5.0386(1.082 %) NAV as on 25 Apr 2024
Scheme Objective: The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
Performance (As on 25 Apr 2024)
| 6 month returns | 1 year returns | 3 year returns | 5 year returns | Returns since inception | |
|---|---|---|---|---|---|
| Scheme | 26.19 % | 53.71 % | 17.08 % | 23.76 % | 18.37 % |
| NIFTY 500 | 24.50 % | 39.42 % | 19.84 % | 16.71 % | N/A |
Portfolio
Sector funds focus their entire portfolio on one particular sector such as banking, infrastructure, or pharmaceuticals. These funds can have very high concentration in their top few stocks. A sector fund can deliver outsized returns compared to the market when the sector is in market favour during a rising market. These funds can be prolonged underperformers if markets donu2019t pick up the theme or if the sector is going through a bad patch. These funds require well-timed entry at the low point and an exit at the high point in order to see returns.
Sector funds suit investors with very high risk appetites, and who have the knowledge and ability to track sector performance.
Short-term: Holding period is less than 12 months.
Taxation: Capital gains are taxed at 15%
Long-term: Holding period is 12 months or more.
Taxation: Capital gains up to Rs 100,000 each financial year is tax-exempt. Remaining capital gains is taxed at 10%. For investments made on or before January 31st, 2018: Capital gain up to this date is tax-free.
